In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Progyny’s current price sits well below the PERT-weighted fair value of $53.55, implying significant upside but with high volatility and downside risk (75% below current price in scenarios). Valuations vary widely, from DCF’s conservative $22.54 midpoint to P/E’s inflated $252.06 midpoint, reflecting sensitivity to growth assumptions and profitability constraints. Strong liquidity and low leverage contrast with modest growth and profitability, indicating mixed risk-reward dynamics.